National Health Plan (NHP) 2021–2030 articulates a vision of “a healthy and prosperous nation where health and wellbeing are enjoyed by all,” anchored in evidence-based innovation as a fundamental ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

Researchers at the Josep Carreras Leukaemia Research Institute propose a new view of cancer based on spatial hallmark ecosystems and its evolution during cancer progression. This conceptual framework ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ('Tonix” or the 'Company”), a fully integrated, commercial biotechnology ...

Therapeutic progress in lung squamous cell carcinoma has lagged, with recent antiangiogenic–checkpoint inhibitor combinations failing primary endpoints despite improved safety, underscoring unmet need ...

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in the coming years.

False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a promising tool to prevent and treat it.

This week, Bobbi Conner talks with MUSC's Dr. Andrea Abbott about right-sizing, or tailoring breast cancer treatment to the individual patient.

The Real Housewives of Atlanta Season 17 friend Cynthia Bailey debuted a chic hair makeover, complete with micro bangs, for a ...

Melanoma remains the most aggressive and lethal form of skin cancer, characterized by a high mutational burden and complex signaling dysregulation. Over the ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades.

ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.